-
mechanisms, with a track record of creative research in molecular biology, cell biology, genomics, imaging approaches and/or bioinformatics. If selected for this position, you will be expected to: Develop and
-
performed an RNA-seq screen in mouse embryonic stem cells and neural progenitor cells and identified differentially expressed lncRNAs. The proposed studies will build upon these findings and use innovative
-
hematopoietic cell development and hematologic cancers. Based on these basic mechanistic insights, the Laboratory is building innovative therapeutics to treat hematopoietic cancers that are currently without
-
Degradation (TPD) therapeutic strategies to abrogate or rewire cancer cell signaling. We have recently established a new discovery platform to expand the landscape of TPD E3 ligases and targeting modalities
-
neurobiology. We study lethal metastatic cancer. The project aims to define how peripheral nerves in the metastatic tumor environment interact with cancer cells and affect progression, therapy and disease